JP2023539107A5 - - Google Patents
Info
- Publication number
- JP2023539107A5 JP2023539107A5 JP2023512094A JP2023512094A JP2023539107A5 JP 2023539107 A5 JP2023539107 A5 JP 2023539107A5 JP 2023512094 A JP2023512094 A JP 2023512094A JP 2023512094 A JP2023512094 A JP 2023512094A JP 2023539107 A5 JP2023539107 A5 JP 2023539107A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063068251P | 2020-08-20 | 2020-08-20 | |
| US63/068,251 | 2020-08-20 | ||
| US202063111394P | 2020-11-09 | 2020-11-09 | |
| US63/111,394 | 2020-11-09 | ||
| US202163139234P | 2021-01-19 | 2021-01-19 | |
| US63/139,234 | 2021-01-19 | ||
| PCT/US2021/046765 WO2022040461A1 (en) | 2020-08-20 | 2021-08-19 | Methods for preventing and treating cardiac dysfunction and covid-19 with activin a antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539107A JP2023539107A (ja) | 2023-09-13 |
| JPWO2022040461A5 JPWO2022040461A5 (https=) | 2024-08-26 |
| JP2023539107A5 true JP2023539107A5 (https=) | 2024-08-26 |
Family
ID=77774983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512094A Pending JP2023539107A (ja) | 2020-08-20 | 2021-08-19 | アクチビンａアンタゴニストによる心機能障害及びｃｏｖｉｄ－１９の予防及び治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20220056119A1 (https=) |
| EP (1) | EP4200017A1 (https=) |
| JP (1) | JP2023539107A (https=) |
| KR (1) | KR20230051683A (https=) |
| CN (1) | CN116249713A (https=) |
| AU (1) | AU2021327238A1 (https=) |
| CA (1) | CA3189147A1 (https=) |
| IL (1) | IL300362A (https=) |
| MX (1) | MX2023001734A (https=) |
| WO (1) | WO2022040461A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114397453B (zh) * | 2022-03-25 | 2022-06-07 | 江苏美克医学技术有限公司 | 新型冠状病毒突变株的检测试剂盒及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| CL2007002567A1 (es) | 2006-09-08 | 2008-02-01 | Amgen Inc | Proteinas aisladas de enlace a activina a humana. |
| JP5766179B2 (ja) | 2009-04-27 | 2015-08-19 | ノバルティス アーゲー | 筋肉増殖を増加させるための組成物および方法 |
| JP5816170B2 (ja) | 2009-06-26 | 2015-11-18 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 |
| TW201920262A (zh) * | 2013-07-30 | 2019-06-01 | 美商再生元醫藥公司 | 抗活化素ａ之抗體及其用途 |
| PT3286206T (pt) * | 2015-04-22 | 2021-04-01 | Biogen Ma Inc | Novas proteínas híbridas bloqueadoras de ligando actriib para tratar doenças de desgaste muscular |
| WO2018009732A1 (en) * | 2016-07-08 | 2018-01-11 | Regeneron Pharmaceuticals, Inc. | Anti-activin a antibodies and methods of use thereof for treating pulmonary arterial hypertension |
| CA3052625A1 (en) * | 2017-02-06 | 2018-08-09 | Acceleron Pharma Inc. | Compositions and methods for treating heart failure |
| FI3600415T3 (fi) * | 2017-03-24 | 2025-12-05 | Novartis Ag | Aktiviinireseptorin tyypin ii reseptorin vastainen vasta-aine käytettäväksi sydämen vajaatoiminnan hoidossa |
| WO2019005963A1 (en) * | 2017-06-27 | 2019-01-03 | The University Of Chicago | USE OF ACTIVIN TO DETECT POST-PARTUM CARDIAC DYSFUNCTION |
-
2021
- 2021-08-19 IL IL300362A patent/IL300362A/en unknown
- 2021-08-19 MX MX2023001734A patent/MX2023001734A/es unknown
- 2021-08-19 CA CA3189147A patent/CA3189147A1/en active Pending
- 2021-08-19 CN CN202180063332.2A patent/CN116249713A/zh active Pending
- 2021-08-19 KR KR1020237008783A patent/KR20230051683A/ko active Pending
- 2021-08-19 JP JP2023512094A patent/JP2023539107A/ja active Pending
- 2021-08-19 US US17/407,012 patent/US20220056119A1/en not_active Abandoned
- 2021-08-19 AU AU2021327238A patent/AU2021327238A1/en active Pending
- 2021-08-19 WO PCT/US2021/046765 patent/WO2022040461A1/en not_active Ceased
- 2021-08-19 EP EP21770348.7A patent/EP4200017A1/en active Pending
-
2025
- 2025-05-22 US US19/216,288 patent/US20250277021A1/en active Pending